아이즈 / Eyes
Eyes's KOBDi Score is 11.94 as of Sep 2026, down 8.34 points since Apr 2025; it rose in 1 and fell in 1 of the 12 monthly updates. As of Sep 2026 it is ahead of about 17% of companies in its industry, against 17% in Aug 2026 and 38% in Apr 2025. Its strongest position was 39% (Jul 2025) and its weakest 17% (Sep 2026).
A year earlier, in Aug 2025, its score was 20.29 and it was ahead of about 38% of companies in its industry.
| Sep 2026 | 11.94 | ahead of 17% |
| Aug 2026 | 11.94 | ahead of 17% |
| Jul 2026 | 11.94 | ahead of 18% |
| Jun 2026 | 11.94 | ahead of 18% |
| May 2026 | 11.94 | ahead of 18% |
| Apr 2026 | 11.94 | ahead of 18% |
| Mar 2026 | 11.94 | ahead of 19% |
| Feb 2026 | 11.78 | ahead of 17% |
| Dec 2025 | 11.78 | ahead of 17% |
| Aug 2025 | 20.29 | ahead of 38% |
| Jul 2025 | 20.29 | ahead of 39% |
| May 2025 | 20.29 | ahead of 39% |
| Apr 2025 | 20.29 | ahead of 38% |
Where is Eyes located?
Eyes is registered at 대구광역시 북구 호국로43길, South Korea (postal code 41003).
What industry is Eyes in?
Eyes belongs to Wholesale & Retail Trade › Wholesale – Household Goods & Appliances › Medical supplies wholesale business.
How many employees does Eyes have?
Eyes has 1–4 employees.
What is Eyes's KOBDi Score?
11.94 as of September 2026, ahead of about 17% of companies in its industry.
Who are Eyes's competitors?
Similar companies include SPIRUS, 프라임메디케어 and Biodiscovery.
